Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration (FILLY trial)DS Liao et alOphthalmology. Feb...

The risk of uveitis due to prostaglandin analogues in paediatric glaucoma

Archway randomised phase 3 trial of ranibizumab port delivery system for nAMDHolekamp N et alOphthalmology, 2022. 129(3): p. 295-307

Telemedicine in oculoplastic and adnexal surgery: clinicians’ perspectives in the UK

Safety and efficacy of AGN-190584 (Vuity drops) in individuals with presbyopia – the GEMINI 1 phase 3 randomised clinical trial

Virtual clinics for glaucoma care – patients’ and clinicians’ experiences and perceptions: a qualitative evaluation Gunn J, Marks J, Au L, et al Eye (2022)...

This update will answer some of the common questions surrounding herpes zoster ophthalmicus (HZO) and highlight recent research, including several key...

Efficacy, durability, and safety of intravitreal faricimab with extended dosing in patients with DMO

The impact of anticancer drugs on the ocular surface

Safety and efficacy of AGN-190584 in individuals with presbyopia: The Gemini 1 phase 3 randomised clinical trialDr George Waring IV et al

Pilot evaluation for an image-based eyelid lesion management service

Patients not showing up to their scheduled appointments is a significant issue, estimated to cost the New Zealand healthcare system $29 million each year